CONTENTS:
- Alcohol and ischaemic heart disease risk - finally moving beyond interpretation of observational epidemiology [Editorial]. Roerecke M., Rehm J., p. 723-725.
- Has the leaning tower of presumed health benefits from 'moderate' alcohol use finally collapsed? [Editorial]. Chikritzhs T., Stockwell T., Naimi T., Andreasson S., Dangardt F., Liang W., p. 726-727.
- Cocaine's fall and marijuana's rise: questions and insights based on new estimates of consumption and expenditures in US drug markets [For debate]. Caulkins J.P., Kilmer B., Reuter P.H., Midgette G., p. 728-736.
- The rise of marijuana and the fall of cocaine in the United States: for better, for worse? Nosyk B., Wood E., Kerr T., p. 737-738.
- We know too little about demand: comments on 'cocaine's fall'. Weatherburn D., p. 738-739.
- Drug use data, drug use theories and drug use policies in the United States: a combinatorial lack of connections. Des Jarlais D., p. 739-740.
- A socio-cultural view of trends in drug use indicators. Golub A., Elliott L., Bennett A.S., p. 740-741.
- On a search for useful indicators… or not? Zabransky T., p. 741-743.
- Beyond prevalence: importance of estimating drug consumption and expenditures. Caulkins J.P., Kilmer B., Reuter P.H., Midgette G., p. 743-745.
- Gambling in Finland: problem gambling in the context of a national monopoly in the European Union. Tammi T., Castrén S., Lintonen T., p. 746-750.
- Effects of experimental negative affect manipulations on ad libitum smoking: a meta-analysis. Heckman B.W., Carpenter M.J., Correa J.B., Wray J.M., Saladin M.E., Froeliger B., et al., p. 751-760.
- Prevalence of alcohol use disorders in mainland China: a systematic review. Cheng H.G., Deng F., Xiong W., Phillips M.R., p. 761-774.
- Personality, negative affect coping, and drinking alone: a structural equation modeling approach to examine correlates of adolescent solitary drinking. Creswell K.G., Chung T., Wright A.G.C., Clark D.B., Black J.J., Martin C.S., p. 775-783.
- Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency. Howard A.L., Molina B.S.G., Swanson J.M., Hinshaw S.P., Belendiuk K.A., Harty S.C., et al., p. 784-795.
- Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China. Zhou W., Wang X., Zhou S., Xie N., Liu P., Luo L., et al., p. 796-802.
- Commentary on Zhou et al. (2015): Research on methadone maintenance treatment (MMT) as prevention for HCV infection - MMT is not a single variable. Des Jarlais D.C., p. 803-804.
- US federal cocaine essential ('precursor') chemical regulation impacts on US cocaine availability: an intervention time–series analysis with temporal replication. Cunningham J.K., Callaghan R.C., Liu L.-M., p. 805-820.
- Commentary on Cunningham et al. (2015): Essential chemical controls-miracle from a black box? Caulkins J., p. 821-822.
- Prolonged hypogonadism in males following withdrawal from anabolic–androgenic steroids: an under-recognized problem. Kanayama G., Hudson J.I., DeLuca J., Isaacs S., Baggish A., Weiner R., et al., p. 823-831.
- Randomized controlled trial of motivational interviewing for reducing injection risk behaviours among people who inject drugs. Bertrand K., Roy É., Vaillancourt É., Vandermeerschen J., Berbiche D., Boivin J.-F., p. 832-841.
- Prevalence of internet gaming disorder in German adolescents: diagnostic contribution of the nine DSM-5 criteria in a state-wide representative sample. Rehbein F., Kliem S., Baier D., Mößle T., Petry N.M., p. 842-851.
- Efficacy of a smoking prevention programme in Catalan secondary schools: a cluster-randomized controlled trial in Spain. Valdivieso López E., Rey-Reñones C., Rodriguez-Blanco T., Ferre Grau C., Arija V., Barrera Uriarte M.L., et al., p. 852-860.
- Commentary on Valdivieso Lopez et al. (2015): Lessons to be learnt from a randomized controlled trial of smoking prevention in secondary schools. Smith B., Carson K., p. 861-861.
- The comparative efficacy of first- versus second-generation electronic cigarettes in reducing symptoms of nicotine withdrawal. Lechner W.V., Meier E., Wiener J.L., Grant D.M., Gilmore J., Judah M.R., et al., p. 862-867.
- Biochemically verified smoking cessation and vaping beliefs among vape store customers. Tackett A.P., Lechner W.V., Meier E., Grant D.M., Driskill L.M., Tahirkheli N.N., et al., p. 868-874.
- Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'. Levin F.R., Mariani J.J., Bisaga A., Nunes E.V., p. 875-876.